Neoadjuvant CAPEOX Versus Upfront Surgery for Locally Advanced Colon Cancer With Elevated CEA: A Single-Center, Open-Label, Randomized Controlled Trial

Clinical trial NCT07413146 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07413146
Sponsor: Sun Yat-sen University
Status: NOT_YET_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Minimal Residual Disease Immunoscore Neoadjuvant Chemotherapy Colon Cancer (Stage II &Amp; III)

Start date: 2026-02-24
Primary completion: 2027-02-28
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.